Innovation
In this section:
- Terms of use
- Privacy Notice
- Accessibility
- Cookie Policy
- ©2024 Freeline
Bringing new innovative therapies to the people who need them.
We are advancing our innovative therapies, based on our next-generation proprietary AAV platform technology.
Our proprietary platform technology includes a novel AAV capsid, which enables high levels of expressed protein, making it possible for gene therapy to potentially address a broad range of diseases.
Link to: Our platform
Our platform
Our innovative platform technology is being used to develop AAV-based gene therapies.
Link to: Collaboration & partnerships
Collaboration & partnerships
Collaboration, partnerships and grants are part of our business model.
We are looking for talented people to join the team